Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw

Tomoko Higuchi, Yoshihiko Soga, Misato Muro, Makoto Kajizono, Yoshihisa Kitamura, Toshiaki Sendo, Akira Sasaki

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw'. Together they form a unique fingerprint.

Medicine & Life Sciences